Microfluidic technologies serve an essential role in the field of cancer research as well as progressing personalized medicine. By providing high-quality and customized solutions and services with our state-of-the-art Microfluidic platforms, Creative Biolabs is a reliable partner for cancer diagnosis based on Microfluidic technology to support your specific diagnosis requirements effectively.

Cancer Diagnosis based on Microfluidics

Since cancer becomes the most common cause of death globally, early diagnosis is the most important cancer issue. Thus, low-cost and point-of-care diagnosis tools and technologies are desperately needed to enable cancer management and reduce mortality rates. Microfluidic technology holds great promise in cancer diagnosis and serves as an emerging tool for understanding cancer biology. Inherently, Microfluidic platforms are suitable for analyzing possible cancer biomarkers in whole blood, including cell-free DNA, miRNA, proteins, exosomes, and circulating tumor cells (CTCs) to monitor cancers. For example:

(1) CTCs can be separated from whole blood using several Microfluidic techniques.

(2) Cell-free DNA can also be detected by Microfluidic digital PCR or electrochemical biosensors.

(3) Exosomes can be captured and analyzed using immunoaffinity approaches based on Microfluidic.

(4) Multiple protein biomarkers can be quantitated by digital or analog immunoassays.

Cancer diagnosis based on Microfluidics.Fig.1 Cancer diagnosis based on Microfluidics. (Garcia-Cordero, 2020)

Advantages of Cancer Diagnosis based on Microfluidics

The development of early cancer diagnostic protocols using Microfluidic technology is considered a promising avenue to decrease mortality from cancer and improve outcomes. Microfluidic technology offers a non-invasive alternative for cancer diagnosis and disease management due to its high sensitivity, high throughput, less material-consumption, low cost, and precise liquid controlling capabilities. These characteristics make the designed Microfluidic platform a promising tool in separating and analyzing circulating tumor biomarkers for point-of-care (POC) diagnosis, prognosis, and monitoring.

Our Cancer Diagnosis Services

Creative Biolabs is a leading diagnostic service company with a robust and standardized Microfluidic platform supporting cancer diagnosis. To meet the needs of your specific projects, Creative Biolabs now offers a series of custom cancer diagnosis services as follows:

Based on our robust and standardized diagnosis platform and Microfluidic technology, Creative Biolabs is a global leading diagnostic service company. Our specialized scientist team provides tailored services and full technical support to all of our customers. Please feel free to contact us for more details, and we will find the best solution for your needs.


  1. Garcia-Cordero, J.L.; Maerkl, S.J. Microfluidic systems for cancer diagnostics. Current Opinion in Biotechnology. 2020, 65, pp.37-44.

For Research Use Only.

Online Inquiry

*E-mail Address:
*Service & Products Interested:
Project Description:

Contact Us




Follow us on:
Copyright © 2021 Creative Biolabs.
Inquiry Basket